Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG) zur Lancet-Studie „Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metaanalysis of the worldwide epidemiological evidence“ (29. August 2019; doi:10.1016/S0140-6736(19)31709-X)
2021 ◽
Vol 18
(01)
◽
pp. 23-24
2021 ◽
Vol 18
(01)
◽
pp. 25-26
2020 ◽
Vol 80
(02)
◽
pp. 153-153
◽
2015 ◽
Vol 138
(8)
◽
pp. 1905-1914
◽
Keyword(s):
Keyword(s):
2017 ◽
Keyword(s):